Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Gritstone bio Inc GRTSQ

Healthcare Biotechnology
Gritstone bio, Inc. is a biotechnology company. The Company discovers, develops, manufactures and delivers next generation cancer and infectious disease immunotherapy candidates. It has developed two vectors that it deploys with the aim of eliciting the desired immune response: self-amplifying mRNA (samRNA) and chimpanzee adenovirus (ChAd). Its two oncology programs in clinical-stage... see more

Recent & Breaking News (PINL:GRTSQ)

Gritstone bio Announces Strengthening of Maturing Phase 2 PFS Data for GRANITE Study and Provides Business Update

GlobeNewswire November 11, 2024

Gritstone bio Takes Action to Preserve Value and Strengthen Capital Structure

Business Wire October 10, 2024

Gritstone bio Announces Interim Phase 2 Data for GRANITE Individualized Neoantigen Targeting Immunotherapy in Frontline Metastatic Microsatellite Stable Colorectal Cancer

GlobeNewswire September 30, 2024

Investors Have The Opportunity To Lead The Gritstone bio, Inc. Securities Fraud Lawsuit With The Schall Law Firm

Accesswire August 15, 2024

Gritstone bio Reports Second Quarter 2024 Financial Results and Provides Corporate Updates

GlobeNewswire August 13, 2024

Investors Are Invited To Take The Lead In The Gritstone Bio Inc Securities Fraud Case With The Schall Law Firm

Accesswire August 7, 2024

GRTS Investors Have The Opportunity To Lead Gritstone Bio Inc Securities Fraud Lawsuit With The Schall Law Firm

Accesswire August 6, 2024

Levi & Korsinsky Notifies Gritstone bio, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - GRTS

Accesswire August 6, 2024

GRTS DEADLINE TODAY: ROSEN, LEADING INVESTOR COUNSEL, Encourages Gritstone bio, Inc. Investors to Secure Counsel Before Important August 6 Deadline in Securities Class Action - GRTS

Newsfile August 6, 2024

GRTS Investors Have Opportunity to Join Gritstone bio, Inc. Fraud Investigation with the Schall Law Firm

Business Wire August 6, 2024

GRTS LAWSUIT ALERT: Levi & Korsinsky Notifies Gritstone bio, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline

Accesswire August 6, 2024

GRTS Investors Have the Opportunity to Lead Gritstone bio, Inc. Securities Fraud Lawsuit with the Schall Law Firm

PR Newswire August 6, 2024

Gritstone bio, Inc. Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before August 6, 2024 to Discuss Your Rights - GRTS

Accesswire August 6, 2024

GRTS INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Gritstone bio, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

Newsfile August 6, 2024

Shareholders of Gritstone bio, Inc. Should Contact Levi & Korsinsky Before August 6, 2024 to Discuss Your Rights - GRTS

PR Newswire August 6, 2024

August 6, 2024 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against - GRTS

Accesswire August 6, 2024

FINAL GRTS DEADLINE: Bronstein, Gewirtz & Grossman LLC Reminds Gritstone bio, Inc. Investors to Join the Class Action Lawsuit!

Accesswire August 6, 2024

Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Gritstone bio, Inc.(GRTS) Shareholders

Accesswire August 5, 2024

GRTS DEADLINE TOMORROW: ROSEN, SKILLED INVESTOR COUNSEL, Encourages Gritstone bio, Inc. Investors to Secure Counsel Before Important August 6 Deadline in Securities Class Action - GRTS

Newsfile August 5, 2024

Levi & Korsinsky Reminds Gritstone bio, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of August 6, 2024 - GRTS

Accesswire August 5, 2024